We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Could File Case Against Generic Maker After Suit Dismissal
FTC Could File Case Against Generic Maker After Suit Dismissal
A federal judge awarded the Federal Trade Commission its request to dismiss a pay-for-delay suit that alleges generics drugmaker Watson Laboratories entered an illegal deal with Endo to block the market entry of Opana ER and Lidoderm generics.